[1] Strand N, Anderson MA, Attanti S, Gill B, Wie C, Dawodu A, et al. Diabetic Neuropathy: Pathophysiology Review. Current pain and headache reports. 2024;28(6):481-7.
[2] Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. Locus coeruleus: a new look at the blue spot. Nature Reviews Neuroscience. 2020;21(11):644-59.
[3] Amaral DG, Sinnamon HM. The locus coeruleus: neurobiology of a central noradrenergic nucleus. Progress in neurobiology. 1977;9(3):147-96.
[4] Aston-Jones G, Zhu Y, Card JP. Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool. Journal of Neuroscience. 2004;24(9):2313-21.
[5] Shipley MT, Fu L, Ennis M, Liu WL, Aston‐Jones G. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. Journal of Comparative Neurology. 1996;365(1):56-68.
[6] España JC, Yasoda-Mohan A, Vanneste S. The Locus Coeruleus in Chronic Pain. International Journal of Molecular Sciences. 2024;25(16):8636.
[7] Chapa-Oliver AM, Mejía-Teniente L. Capsaicin: From plants to a cancer-suppressing agent. Molecules. 2016;21(8):931.
[8] Wang L, Wang DH. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation. 2005;112(23):3617-23.
[9] Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1: an update. European journal of biochemistry. 2004;271(10):1814-9.
[10] Samanta A, Hughes TE, Moiseenkova-Bell VY. Transient receptor potential (TRP) channels. Membrane protein complexes: Structure and function. 2018:141-65.
[11] Arora V, Campbell JN, Chung M-K. Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain. Pharmacology & therapeutics. 2021;220:107743.
[12] Wang Y, Kedei N, Wang M, Wang QJ, Huppler AR, Toth A, et al. Interaction between protein kinase Cμ and the vanilloid receptor type 1. Journal of biological chemistry. 2004;279(51):53674-82.
[13] Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, et al. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. Journal of Neuroscience. 2007;27(50):13739-49.
[14] Listos J, Łupina M, Talarek S, Mazur A, Orzelska-Górka J, Kotlińska J. The mechanisms involved in morphine addiction: an overview. International journal of molecular sciences. 2019;20(17):4302.
[15] Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nature reviews Disease primers. 2019;5(1):1-18.
[16] Sharma S, Kulkarni SK, Chopra K. Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundamental & clinical pharmacology. 2007;21(1):89-94.
[17] Chung M-K, Campbell JN. Use of capsaicin to treat pain: mechanistic and therapeutic considerations. Pharmaceuticals. 2016;9(4):66.
[18] Liao HT, Lee HJ, Ho YC, Chiou LC. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor‐mediated endocannabinoid retrograde disinhibition. British journal of pharmacology. 2011;163(2):330-45.
[19] Vertes RP. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience. 2006;142(1):1-20.